A detailed history of Conservest Capital Advisors, Inc. transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Conservest Capital Advisors, Inc. holds 5,051 shares of PPH stock, worth $451,559. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,051
Previous 5,029 0.44%
Holding current value
$451,559
Previous $477,000 8.81%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$86.03 - $94.92 $1,892 - $2,088
22 Added 0.44%
5,051 $435,000
Q1 2024

May 02, 2024

SELL
$82.63 - $90.89 $38,670 - $42,536
-468 Reduced 8.51%
5,029 $456,000
Q4 2023

Feb 05, 2024

BUY
$74.32 - $81.37 $408,537 - $447,290
5,497 New
5,497 $447,000
Q4 2017

Jan 10, 2018

SELL
N/A
-5,000 Closed
0 $0
Q3 2017

Oct 12, 2017

BUY
N/A
5,000
5,000 $289,000

Others Institutions Holding PPH

About VANECK ETF TR VANECK PHARMACEU


  • Ticker PPH
  • Sector ETFs
  • Industry ETFs
More about PPH
Track This Portfolio

Track Conservest Capital Advisors, Inc. Portfolio

Follow Conservest Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conservest Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conservest Capital Advisors, Inc. with notifications on news.